Any feedback?
Literature summary for 1.17.4.4 extracted from
- The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements in an adult Turkish population (2010), Heart Vessels, 25, 155-162.
Application
| Application | Comment | Organism |
|---|---|---|
| medicine | VKORC1 genotype affects daily dose requirements and time to therapeutic international normalized ratio in Turkish patients receiving warfarin for anticoagulation | Homo sapiens |
Inhibitors
| Inhibitors | Comment | Organism | Structure |
|---|---|---|---|
| warfarin | - |
Homo sapiens |  |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | - |
- |
- |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| vitamin K epoxide reductase | - |
Homo sapiens |
| VKORC1 | - |
Homo sapiens |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
